Research and experimental development services | Tenderlake

Research and experimental development services

Contract Value:
-
Notice Type:
Contract Notice
Published Date:
27 October 2023
Closing Date:
29 November 2023
Location(s):
PL911 Miasto Warszawa (PL Poland/POLSKA)
Description:
Manufacture and delivery of drugs and placebo for the purposes of the project: "Evaluation of the efficacy and safety of Budesonide prolonged-release in children (...)

Full name of the procedure: Manufacture and delivery of drugs and placebo for the purposes of the project: "Evaluation of the efficacy and safety of Budesonide with prolonged release in children with primary IgA nephropathy - a multicenter, phase III interventional, randomized, placebo-controlled, double-blind study (SABINE)"

1. The subject of the contract is the production and delivery of drugs and placebo, hereinafter referred to as IMP, for the purposes of the project: "Evaluation of the efficacy and safety of Budesonide with prolonged release in children with primary IgA nephropathy - a multicenter, phase III interventional trial, randomized, placebo-controlled, double-blind (SABINE)",

2. A detailed description of the object of the contract is set out in Annex 2 to the SWZ and in the draft contract constituting Annex 6 to the SWZ.

Download full details as .pdf
The Buyer:
Warszawski Uniwersytet Medyczny
CPV Code(s):
33600000 - Pharmaceutical products
73100000 - Research and experimental development services